Stay updated on Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial
Sign up to get notified when there's something new on the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page.

Latest updates to the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoChange DetectedThe study has been withdrawn and will no longer proceed due to disapproval by the internal scientific review committee. The previously mentioned recruitment date has also been removed.SummaryDifference4%
- Check23 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been removed and replaced with the same phrase, suggesting a possible formatting or presentation change rather than a substantive content update.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference5%
Stay in the know with updates to Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cladribine & LoDAC vs. HMA & Venetoclax Clinical Trial page.